JP2024506041A5 - - Google Patents
Info
- Publication number
- JP2024506041A5 JP2024506041A5 JP2023547694A JP2023547694A JP2024506041A5 JP 2024506041 A5 JP2024506041 A5 JP 2024506041A5 JP 2023547694 A JP2023547694 A JP 2023547694A JP 2023547694 A JP2023547694 A JP 2023547694A JP 2024506041 A5 JP2024506041 A5 JP 2024506041A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- pharmaceutical composition
- composition according
- administration period
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163147060P | 2021-02-08 | 2021-02-08 | |
| US63/147,060 | 2021-02-08 | ||
| PCT/EP2022/053030 WO2022167690A1 (en) | 2021-02-08 | 2022-02-08 | Amiselimod for preventing, treating, or ameliorating ulcerative colitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506041A JP2024506041A (ja) | 2024-02-08 |
| JP2024506041A5 true JP2024506041A5 (enExample) | 2025-02-14 |
Family
ID=80447376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547694A Pending JP2024506041A (ja) | 2021-02-08 | 2022-02-08 | 潰瘍性大腸炎を予防、処置、または改善するためのアミセリモド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240299318A1 (enExample) |
| EP (1) | EP4288041A1 (enExample) |
| JP (1) | JP2024506041A (enExample) |
| CN (1) | CN116940350A (enExample) |
| AU (1) | AU2022217475A1 (enExample) |
| CA (1) | CA3207440A1 (enExample) |
| MX (1) | MX2023009249A (enExample) |
| TW (1) | TW202245742A (enExample) |
| WO (1) | WO2022167690A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025134072A1 (en) * | 2023-12-21 | 2025-06-26 | Bausch Health Ireland Limited | Methods for preventing, treating, or ameliorating ulcerative colitis in certain patient populations with amiselimod |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| BRPI0619894B8 (pt) | 2005-12-15 | 2021-05-25 | Mitsubishi Tanabe Pharma Corp | composto de amina e composição farmacêutica |
| JP5657565B2 (ja) | 2008-12-22 | 2015-01-21 | ノバルティス アーゲー | Ｓ１ｐ受容体アゴニストの投与レジメン |
| MA40774A (fr) * | 2014-10-01 | 2017-08-08 | Respivert Ltd | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 |
| PL3242666T3 (pl) * | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| JP2018527406A (ja) * | 2015-08-11 | 2018-09-20 | アカール ファーマ ピーティーワイ リミテッドＡｋａａｌ Ｐｈａｒｍａ Ｐｔｙ Ｌｔｄ | Ｓ１ｐ受容体モジュレーターを含む組成物 |
| WO2020051568A1 (en) * | 2018-09-08 | 2020-03-12 | Wen Tan | NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS |
-
2022
- 2022-02-08 AU AU2022217475A patent/AU2022217475A1/en active Pending
- 2022-02-08 WO PCT/EP2022/053030 patent/WO2022167690A1/en not_active Ceased
- 2022-02-08 CN CN202280013674.8A patent/CN116940350A/zh active Pending
- 2022-02-08 CA CA3207440A patent/CA3207440A1/en active Pending
- 2022-02-08 MX MX2023009249A patent/MX2023009249A/es unknown
- 2022-02-08 EP EP22705759.3A patent/EP4288041A1/en active Pending
- 2022-02-08 JP JP2023547694A patent/JP2024506041A/ja active Pending
- 2022-02-08 US US18/276,120 patent/US20240299318A1/en active Pending
- 2022-02-08 TW TW111104482A patent/TW202245742A/zh unknown